Loading…
Synthesis, Hydrolytic Activation and Cytotoxicity of Etoposide Prodrugs
Two 4′-propylcarbonoxy derivatives ( 2, 3) of etoposide ( 1), a topoisomerase II inhibitor, were synthesized and evaluated as potential prodrugs for anticancer therapy. Their activation via hydrolysis mechanisms was determined as a function of pH in buffer solutions, in human serum and in the presen...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2002-02, Vol.12 (4), p.557-560 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Two 4′-propylcarbonoxy derivatives (
2,
3) of etoposide (
1), a topoisomerase II inhibitor, were synthesized and evaluated as potential prodrugs for anticancer therapy. Their activation via hydrolysis mechanisms was determined as a function of pH in buffer solutions, in human serum and in the presence of carboxyl ester hydrolase. Cytotoxicity was determined on various tumor cell lines and compared to the parent compound. On cell lines exhibiting resistance to etoposide we observed an enhanced cytotoxicity of the prodrugs of up to three orders of magnitude.
Two prodrugs of the topoisomerase II inhibiting antitumor drug etoposide incorporating either hydrophilic or hydrophobic groups and differing in their substrate specificity for the activating enzyme carboxyl esterase were prepared. These new prodrugs show dramatically different activation kinetics and completely circumvent MDR-1 drug resistance. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/S0960-894X(01)00801-0 |